A tiny Long Island biotech firm is testing a drug designed to shrink fatty tumors that could be the answer to shedding unwanted fat without resorting to stressful dieting and exercise or risky liposuction.
Claims of fat “melting” by products or treatments have always proved to be too good to be true. But Biospecifics Technologies Corp. of Lynbrook, New York, says it has seen “promising results” in early clinical trials of an injectable treatment for reducing lipomas.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!